Trial intelligence / Profile preview

Tapentadol PR versus oxycodone CR in osteoarthritis knee pain

2012-003770-11Phase 2Terminated

Sponsor
C4Pain
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in knee osteoarthritis (OA) comparing Tapentadol PR with Oxycodone CR (2 arms). Primary endpoint: Experimental mechanism based pain measures. Started Nov 2012; status: terminated.

02

Drugs

tapentadoloxycodone
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2012-003770-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003770-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call